Equivalent price position
This pack size cannot yet be normalized reliably for a unit-price comparison. MedInfoBase does not estimate unit prices from ambiguous pack descriptions.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Erythromycin ethylsuccinate + Sulfisoxazole acetyl
- Therapeutic area
- Anti-infectives
- Drug class
- Macrolide antibacterials
- ATC
- J01RA
- Strength
- 200 mg + 600 mg/5 mL
- Dosage form
- Powder for oral suspension
- Pack
- 1,s (60 ml)
- Registration no.
- 093674
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-09-25 03:02
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
No change in the official DRAP price is recorded for this pack (1,s (60 ml)). Current price PKR 72.14, effective 13 Jan 2026.
Cite this price history
MedInfoBase. Eryzol 200 mg + 600 mg/5 mL, 1,s (60 ml): official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/eryzol-200-mg-600-mg-5-ml-093674-1s-60-ml-magns-pharmaceuticals/ (accessed 25 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 72.14 | 2026-01-13 | 2026-09-22 | DRAP PharmaPrice Index (recovered from snapshot #84) | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 093674Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.